Article Versions Notes

Kalebic D, Gao L-J, Martinez-Gualda B, Karim M, Saul S, Tran DHN, Rozenski J, Persoons L, Schols D, Dehaen W, et al. Structure–Activity Relationship Study of 3-Alkynyl-6-aryl-isothiazolo[4,3-b]pyridines as Dual Inhibitors of the Lipid Kinases PIKfyve and PIP4K2C. Pharmaceuticals. 2025; 18(9):1341. https://doi.org/10.3390/ph18091341

Kalebic, Demian, Ling-Jie Gao, Belén Martinez-Gualda, Marwah Karim, Sirle Saul, Do Hoang Nhu Tran, Jef Rozenski, Leentje Persoons, Dominique Schols, Wim Dehaen, and et al. 2025. "Structure–Activity Relationship Study of 3-Alkynyl-6-aryl-isothiazolo[4,3-b]pyridines as Dual Inhibitors of the Lipid Kinases PIKfyve and PIP4K2C" Pharmaceuticals 18, no. 9: 1341. https://doi.org/10.3390/ph18091341

Kalebic, D., Gao, L.-J., Martinez-Gualda, B., Karim, M., Saul, S., Tran, D. H. N., Rozenski, J., Persoons, L., Schols, D., Dehaen, W., Einav, S., & De Jonghe, S. (2025). Structure–Activity Relationship Study of 3-Alkynyl-6-aryl-isothiazolo[4,3-b]pyridines as Dual Inhibitors of the Lipid Kinases PIKfyve and PIP4K2C. Pharmaceuticals, 18(9), 1341. https://doi.org/10.3390/ph18091341